What Urologists are saying:

The robot knows exactly where in the prostate the template and targeted biopsies were taken from, so if and when focal therapy is delivered, it's directed precisely at the sites of cancer.

That’s incredibly powerful.

Dr. Alexander Kutikov

Chair, Department of Urology
Fox Chase Cancer Center Temple Health
Philadelphia, PA, US

I am excited about the Insight Medbotics MRI Robot and see its potential for increasing urologic involvement in MRI-guided interventions.

This is an appropriate vision for where the field is going, it will facilitate the planning for biopsy and treatment.

Dr. Preston Sprenkle

Associate Professor of Urology
Director, Urology Research Fellowship
Yale Cancer Center
New Haven, CT, US

MRI has become a part of everyday life in Urology. Glenn is designed to be intuitive for urologists. It’s an easy software interface, and I’m impressed by the angles.

On focal, it will be a game changer and may be a challenger to da Vinci robotic prostatectomies.

Dr. Edward Matsumoto

Urologist
St. Joseph's Healthcare
Hamilton, ON, Canada

This means I can take fewer biopsy cores with increased diagnostic accuracy...a win-win.

Dr. Jeffrey C. Bassett

Chair, Urologic Oncology
Hoag Medical Group
Newport Beach, CA, US

We believe precision in prostate cancer care means everything.

We envision a future of cancer care that imposes less on patients and minimizes side effects with the assurance of finding and treating the cancer. So, patients won’t have to choose between peace of mind in knowing the cancer is treated and doing the things that matter most to them.

For prostate cancer, that means striving to work within the confines of the prostate capsule—as small as a walnut—in order to treat the cancer

MRI Robotics for Urologic Interventional MRI

Urologists seeking better precision for their patients and tired of MRI substitutes know there’s nothing like the real thing when it comes to seeing clearly.

But, interventional MRI has been impractical and inaccessible for urologists.

Until now...

Meet Glenn^TM

Recent News

Dr. Preston Sprenkle Joins Insight Medbotics’ Clinical Advisory Board

September 24, 2025

Insight Medbotics, an interventional oncology company advancing precision in cancer care through its MRI-compatible robotics, is pleased to welcome Dr. Preston Sprenkle, an Associate Professor of Urology at Yale University, to the company’s clinical advisory board.

Meet Glenn™, Insight Medbotics’ Next-Generation MRI-Compatible Robotics System for Prostate Cancer Care

September 18, 2025

System leveraging 510k-cleared IGAR technology attracts growing interest from urologists across U.S. hospitals and private practices

CEO Fazila Seker among keynote talks at TechTO’s Health Toronto

September 11, 2025

Insight Medbotics CEO and Board of Directors member Fazila Seker was among the healthcare leaders speaking at TechTO’s Health Toronto event on September 10, 2025. Her talk, “The Craft of Building Traction for your MedTech Startup: Untold Stories from the Road Less Traveled,” helped builders in the audience to understand their target customers, how industry alliances work, and gain the insight needed to create traction in a challenging technology market.

Summer Round-Up: New robotics system gets strong feedback from urologists

September 4, 2025

We’ve had an exciting summer at Insight Medbotics. Our team has achieved several new milestones, which include completing a new robotics system in the urology space. Designed for MRI compatibility while improving the standard of precision in prostate cancer care, this robotics system offers urologists intuitive MRI access to address the guesswork of traditional ultrasound guidance.

Insight Medbotics Announces World’s First FDA-Cleared, MRI-Compatible Robot

September 13, 2023

The IGAR system is the first and only robotic guidance and placement system cleared to work inside an MRI bore, one of the most challenging hospital environments.

Made for precision in prostate cancer care